Evidence map›Paper›PMID 42802156›Full record

ArticleNature communications2026

Autoinhibition of untimely DNA binding by structural disorder in the full-length peroxisome proliferator-activated receptors (PPARs).

Milena R Lalic, Elisabeth G K Thomsen, F Emil Thomasen, Aditya Udupa, Emma Salehian Andersen, Sonja Kuppermann, Casper G Christensen, Emma Holm-Olesen, Daniel Saar, Andreas Prestel and 9 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Milena R Lalic *REPIN, Department of Biology, University of Copenhagen, Copenhagen N, Denmark.ORCID http://orcid.org/0009-0007-9790-7846
Elisabeth G K Thomsen *REPIN, Department of Biology, University of Copenhagen, Copenhagen N, Denmark.
F Emil ThomasenLinderstrøm-Lang Centre for Protein Science, Department of Biology, University of Copenhagen, Copenhagen N, Denmark.ORCID http://orcid.org/0000-0002-2096-4873
Aditya UdupaDepartment of Molecular and Cell Biology, University of California, Berkeley, CA, USA.
Emma Salehian AndersenREPIN, Department of Biology, University of Copenhagen, Copenhagen N, Denmark.ORCID http://orcid.org/0009-0002-2813-2630
Sonja KuppermannREPIN, Department of Biology, University of Copenhagen, Copenhagen N, Denmark.ORCID http://orcid.org/0009-0000-4029-2683
Casper G ChristensenREPIN, Department of Biology, University of Copenhagen, Copenhagen N, Denmark.ORCID http://orcid.org/0009-0002-5348-5761
Emma Holm-OlesenLinderstrøm-Lang Centre for Protein Science, Department of Biology, University of Copenhagen, Copenhagen N, Denmark.ORCID http://orcid.org/0009-0002-9061-6919
Daniel SaarREPIN, Department of Biology, University of Copenhagen, Copenhagen N, Denmark.
Andreas PrestelREPIN, Department of Biology, University of Copenhagen, Copenhagen N, Denmark.ORCID http://orcid.org/0000-0002-5459-9608
Lukas W BauerREPIN, Department of Biology, University of Copenhagen, Copenhagen N, Denmark.
Joseph McKennaDepartment of Molecular and Cell Biology, University of California, Berkeley, CA, USA.ORCID http://orcid.org/0000-0002-3921-4933
Johan G OlsenREPIN, Department of Biology, University of Copenhagen, Copenhagen N, Denmark.ORCID http://orcid.org/0000-0001-8805-6372
Susanne MandrupFunctional Genomics and Metabolism Research Unit, Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark.ORCID http://orcid.org/0000-0002-0961-5787
Rasmus Hartmann-PetersenREPIN, Department of Biology, University of Copenhagen, Copenhagen N, Denmark.ORCID http://orcid.org/0000-0002-4155-7791
Cy M JeffriesEuropean Molecular Biology Laboratory (EMBL), Hamburg Unit, Deutsches Elektronen-Synchrotron, Hamburg, Germany.
Max V StallerDepartment of Molecular and Cell Biology, University of California, Berkeley, CA, USA.ORCID http://orcid.org/0000-0001-9094-5697
Kresten Lindorff-LarsenLinderstrøm-Lang Centre for Protein Science, Department of Biology, University of Copenhagen, Copenhagen N, Denmark.ORCID http://orcid.org/0000-0002-4750-6039
Birthe B KragelundREPIN, Department of Biology, University of Copenhagen, Copenhagen N, Denmark. bbk@bio.ku.dk.ORCID http://orcid.org/0000-0002-7454-1761

Funding

EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 101119633Novo Nordisk Fonden (Novo Nordisk Foundation) NNF18OC0032608Novo Nordisk Fonden (Novo Nordisk Foundation) NNF18OC0032996Novo Nordisk Fonden (Novo Nordisk Foundation) NNF18OC0033926Novo Nordisk Fonden (Novo Nordisk Foundation) NNF18OC0033950Novo Nordisk Fonden (Novo Nordisk Foundation) NNF21OC0071057
6 · The paper itself

Abstract

Structural disorder in nuclear receptors is essential for gene transcription, but mechanisms are lacking. Using experiment and computation, including residue-resolution NMR, we demonstrate how structural disorder in full-length peroxisome proliferator-activated receptors (PPARs) contributes to function. We show that the disordered AB domain of PPARγ and PPARα interact dominantly and dynamically with the DNA binding domain (DBD) via two regions that, when tested in cells, constitute active transactivation domains. For PPARγ, we provide an integrative structural model of the full-length protein, and show that upon DNA binding to the DBD, but not by ligand binding to the LBD, the AB domains are released to an open, accessible state. We demonstrate that the interactions between the AB domain and the DBD lead to autoinhibition affecting DNA binding affinity negatively with little effect on DNA binding specificity. We show that autoinhibition is also present in the heterodimer with RXRα, but is less pronounced due to higher DNA binding affinity. Thus, our work suggests a role for the disordered AB domain in preventing untimely DNA binding to the PPAR monomers.

Indexed as

DNAPeroxisome Proliferator-Activated ReceptorsPPAR alphaPPAR gammaAnimalsBinding SitesHumansModels, MolecularProtein BindingProtein DomainsRetinoid X Receptor alphaDNAPeroxisome Proliferator-Activated ReceptorsPPAR alphaPPAR gammaRetinoid X Receptor alpha

Identifiers

PMID42802156
PMCPMC13616897

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.